Faculty Opinions recommendation of Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.

Abstract

This very interesting ongoing trial will evaluate the need to continue with drugs that block the renin-angiotensin system in patients with advanced chronic kidney disease (CKD). This article states the rationale and trial design.